Companies: 10,638     total market cap: โ‚ฌ116.357 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Exelixis
EXEL
#1694
Rank
โ‚ฌ10.25 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
38,10ย โ‚ฌ
Share price
-0.02%
Change (1 day)
11.91%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.56 Billion

According to Exelixis's latest financial reports the company's total liabilities are โ‚ฌ0.56 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exelixis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.67 B10.15%
2023-12-31โ‚ฌ0.61 B12.91%
2022-12-31โ‚ฌ0.54 B51.76%
2021-12-31โ‚ฌ0.35 B70.61%
2020-12-31โ‚ฌ0.20 B17.77%
2019-12-31โ‚ฌ0.17 B51.25%
2018-12-31โ‚ฌ0.11 B-61.81%
2017-12-31โ‚ฌ0.30 B-35.89%
2016-12-31โ‚ฌ0.48 B11.26%
2015-12-31โ‚ฌ0.43 B20.13%
2014-12-31โ‚ฌ0.36 B13.82%
2013-12-31โ‚ฌ0.31 B-1.42%
2012-12-31โ‚ฌ0.32 B37.77%
2011-12-31โ‚ฌ0.23 B-47.38%
2010-12-31โ‚ฌ0.44 B25.12%
2009-12-31โ‚ฌ0.35 B8.07%
2008-12-31โ‚ฌ0.32 B46.42%
2007-12-31โ‚ฌ0.22 B-3.17%
2006-12-31โ‚ฌ0.23 B-0.64%
2005-12-31โ‚ฌ0.23 B31.04%
2004-12-31โ‚ฌ0.17 B13.78%
2003-12-31โ‚ฌ0.15 B-0.12%
2002-12-31โ‚ฌ0.15 B26.03%
2001-12-31โ‚ฌ0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
GlaxoSmithKline
GSK
โ‚ฌ52.63 B 9,145.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚ฌ56.71 B 9,861.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ66.68 B 11,612.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ67.24 B 11,711.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ69.16 B 12,047.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 17,028.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.31 B 17,345.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚ฌ36.35 M-93.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚ฌ62.17 M-89.08%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com